CN101556280B - 检测氯胺酮和甲基苯丙胺的荧光微球免疫层析检测卡及其制备方法 - Google Patents
检测氯胺酮和甲基苯丙胺的荧光微球免疫层析检测卡及其制备方法 Download PDFInfo
- Publication number
- CN101556280B CN101556280B CN 200910085054 CN200910085054A CN101556280B CN 101556280 B CN101556280 B CN 101556280B CN 200910085054 CN200910085054 CN 200910085054 CN 200910085054 A CN200910085054 A CN 200910085054A CN 101556280 B CN101556280 B CN 101556280B
- Authority
- CN
- China
- Prior art keywords
- detection
- ketamine
- fluorescent microsphere
- card
- test strips
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 98
- 239000004005 microsphere Substances 0.000 title claims abstract description 68
- 229960003299 ketamine Drugs 0.000 title claims abstract description 53
- 229960001252 methamphetamine Drugs 0.000 title claims abstract description 53
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 title claims abstract description 53
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 238000003317 immunochromatography Methods 0.000 title abstract 3
- 238000003908 quality control method Methods 0.000 claims abstract description 36
- 239000003365 glass fiber Substances 0.000 claims abstract description 27
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 21
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 5
- 238000012360 testing method Methods 0.000 claims description 71
- 239000013078 crystal Substances 0.000 claims description 35
- 239000000427 antigen Substances 0.000 claims description 25
- 102000036639 antigens Human genes 0.000 claims description 25
- 108091007433 antigens Proteins 0.000 claims description 25
- 239000012528 membrane Substances 0.000 claims description 25
- 102000014914 Carrier Proteins Human genes 0.000 claims description 20
- 108010078791 Carrier Proteins Proteins 0.000 claims description 20
- 239000000020 Nitrocellulose Substances 0.000 claims description 19
- 230000002362 anti-crystal effect Effects 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 239000007921 spray Substances 0.000 claims description 9
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000007853 buffer solution Substances 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000001556 precipitation Methods 0.000 claims description 7
- 239000008363 phosphate buffer Substances 0.000 claims description 6
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims description 5
- 239000000975 dye Substances 0.000 claims description 5
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 238000005507 spraying Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 3
- 108010090804 Streptavidin Proteins 0.000 claims description 3
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229910052707 ruthenium Inorganic materials 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 238000003805 vibration mixing Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- LFHXBXASDAYCRZ-UHFFFAOYSA-N ON1C(CCC1=O)=O.[N] Chemical compound ON1C(CCC1=O)=O.[N] LFHXBXASDAYCRZ-UHFFFAOYSA-N 0.000 claims description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 230000005284 excitation Effects 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 abstract 2
- 229940079938 nitrocellulose Drugs 0.000 abstract 2
- 230000035622 drinking Effects 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
- 239000002105 nanoparticle Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 230000003595 spectral effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 22
- 239000003814 drug Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 229920001213 Polysorbate 20 Polymers 0.000 description 7
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 7
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- 238000004587 chromatography analysis Methods 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000011806 microball Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 235000009120 camo Nutrition 0.000 description 2
- 235000005607 chanvre indien Nutrition 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 229910000071 diazene Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000011487 hemp Substances 0.000 description 2
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- -1 1,2,3,3-tetramethyl indolyl Chemical group 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 229940099433 NMDA receptor antagonist Drugs 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000000534 ion trap mass spectrometry Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000003703 n methyl dextro aspartic acid receptor blocking agent Substances 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000506 psychotropic effect Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910085054 CN101556280B (zh) | 2009-05-20 | 2009-05-20 | 检测氯胺酮和甲基苯丙胺的荧光微球免疫层析检测卡及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910085054 CN101556280B (zh) | 2009-05-20 | 2009-05-20 | 检测氯胺酮和甲基苯丙胺的荧光微球免疫层析检测卡及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101556280A CN101556280A (zh) | 2009-10-14 |
CN101556280B true CN101556280B (zh) | 2013-04-24 |
Family
ID=41174475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910085054 Active CN101556280B (zh) | 2009-05-20 | 2009-05-20 | 检测氯胺酮和甲基苯丙胺的荧光微球免疫层析检测卡及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101556280B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108956974A (zh) * | 2018-05-29 | 2018-12-07 | 郑州左安检测科技有限公司 | 一种检测氯胺酮的试纸条及其制备方法和应用方法 |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103901193A (zh) * | 2012-12-26 | 2014-07-02 | 深圳先进技术研究院 | 苏丹红检测免疫试纸及其制备方法 |
CN103235125A (zh) * | 2013-04-09 | 2013-08-07 | 江西中德生物工程有限公司 | 莱克多巴胺、西马特罗二联胶体金试纸条及其制备方法与用途 |
CN104101703A (zh) * | 2013-04-11 | 2014-10-15 | 南昌大学 | 一种快速检测食品中牛乳过敏原的装置及其制备方法 |
CN104101581A (zh) * | 2013-04-11 | 2014-10-15 | 南昌大学 | 一种快速检测食品中花生致敏蛋白的装置及其制备方法 |
CN104101713A (zh) * | 2013-04-11 | 2014-10-15 | 南昌大学 | 一种快速检测食品中大豆蛋白的装置及其制备方法 |
CN105203528A (zh) * | 2015-09-22 | 2015-12-30 | 深圳市希莱恒医用电子有限公司 | 一种糖化血红蛋白检测装置 |
CN105548098B (zh) * | 2015-12-03 | 2018-07-13 | 中国科学院上海微系统与信息技术研究所 | 一种检测甲基苯丙胺或/和氯胺酮的荧光探针和检测方法 |
CN106841150B (zh) * | 2017-03-17 | 2019-10-15 | 浙江警察学院 | 一种指纹遗留多种毒品识别和指纹成像的方法 |
CN108398412B (zh) * | 2018-03-28 | 2021-10-26 | 韶关学院 | 双抗体夹心免疫竞争法检测布洛芬的量子点免疫层析检测卡及检测方法 |
CN108507989B (zh) * | 2018-03-28 | 2021-10-26 | 韶关学院 | 双抗体夹心免疫竞争法检测奥沙普嗪的量子点免疫层析检测卡及检测方法 |
CN108845152A (zh) * | 2018-05-29 | 2018-11-20 | 郑州左安检测科技有限公司 | 一种检测苯丙胺的试纸条及其制备方法和应用方法 |
CN108845151A (zh) * | 2018-05-29 | 2018-11-20 | 郑州左安检测科技有限公司 | 一种检测甲基苯丙胺的试纸条及其制备方法和应用方法 |
CN109061204A (zh) * | 2018-07-30 | 2018-12-21 | 杭州莱和生物技术有限公司 | 一种荧光免疫检测毛发痕量毒品的试剂盒 |
CN109613230A (zh) * | 2018-12-29 | 2019-04-12 | 上海八通生物科技股份有限公司 | 一种毛发中毒品的快速定量检测方法 |
CN110058012B (zh) * | 2019-04-08 | 2022-03-01 | 石家庄洹众生物科技有限公司 | 同步检测二乙酰吗啡、甲基苯丙胺、氯胺酮和可卡因的荧光免疫试纸组及其制备和使用方法 |
CN111982866B (zh) * | 2020-06-05 | 2022-05-20 | 中国科学院新疆理化技术研究所 | 一种比色荧光猝灭双模检测氯胺酮的方法 |
CN112285358A (zh) * | 2020-09-17 | 2021-01-29 | 上海基灵生物科技有限公司 | 一种用于犬c反应蛋白及胰腺特异性脂肪酶双联检测试剂卡 |
CN113156108A (zh) * | 2021-01-31 | 2021-07-23 | 古镜科技(深圳)有限公司 | 一种毛发毒品五联荧光检测试纸及其制备方法 |
CN114324861A (zh) * | 2021-12-08 | 2022-04-12 | 北京泰格科信生物科技有限公司 | 念珠菌/阴道毛滴虫/阴道加德纳菌抗原联合检测试剂盒及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1818635A (zh) * | 2006-03-15 | 2006-08-16 | 首都师范大学 | 十二种毒品的THz检测方法及其指纹谱 |
-
2009
- 2009-05-20 CN CN 200910085054 patent/CN101556280B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1818635A (zh) * | 2006-03-15 | 2006-08-16 | 首都师范大学 | 十二种毒品的THz检测方法及其指纹谱 |
Non-Patent Citations (5)
Title |
---|
张正威.84例苯丙胺类兴奋剂急性中毒的临床救治分析.《公共卫生和预防医学》.2008,第19卷(第2期),全文. * |
曾立波等.氯胺酮 甲基苯丙胺和吗啡金标单抗试剂盒的研制.《中国法医学杂志》.2008 |
曾立波等.氯胺酮,甲基苯丙胺和吗啡金标单抗试剂盒的研制.《中国法医学杂志》.2008,第23卷(第4期),全文. * |
陈丽等.胶体金免疫层析法在早孕检测中的应用.《医学动物免疫》.2006,(第12期),全文. * |
黄建华等.利用胶体金层析法快速检测尿样中的甲基苯丙胺.《南昌高专学报》.2009,(第80期),全文. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108956974A (zh) * | 2018-05-29 | 2018-12-07 | 郑州左安检测科技有限公司 | 一种检测氯胺酮的试纸条及其制备方法和应用方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101556280A (zh) | 2009-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101556280B (zh) | 检测氯胺酮和甲基苯丙胺的荧光微球免疫层析检测卡及其制备方法 | |
CN102023210A (zh) | 检测恩诺沙星的荧光微球免疫层析检测卡及其制备方法 | |
CN1945331B (zh) | 同步检测多种小分子化合物的试剂的制备及其使用方法 | |
CN101493460B (zh) | 一种荧光微球免疫层析试纸条的制备方法及定量检测方法 | |
CN101435823B (zh) | 检测残留兽药的荧光微球免疫层析试纸条及其制备方法 | |
CN105765388B (zh) | 改进的妊娠测试设备和方法 | |
CN101726596A (zh) | 检测乙肝五项的荧光微球免疫层析检测卡及其制备方法 | |
CN111537748B (zh) | 一种检测人新型冠状病毒IgM抗体的试纸条、试剂盒及其制备方法 | |
CN101576562A (zh) | 检测艾滋病病毒的荧光微球免疫层析检测卡及其制备方法 | |
CN101551398A (zh) | 药物残留竞争型量子点标记免疫层析试纸条及其观测装置 | |
CN102565386B (zh) | 一种磁性荧光微球免疫层析定量检测方法 | |
CN102253222B (zh) | 检测雌激素的方法及其专用试纸 | |
CN102565422B (zh) | 一种定量检测心肌肌钙蛋白t的荧光免疫层析方法及其试剂盒 | |
CN102565423B (zh) | 一种定量检测氮末端脑钠肽的荧光免疫层析方法及其试剂盒 | |
CN85104030A (zh) | 免疫测定方法和装置 | |
CN102520194A (zh) | 一种定量检测人心型脂肪酸结合蛋白的荧光免疫层析方法及其试剂盒 | |
CN103604926B (zh) | 一种免疫层析试纸条检测微囊藻毒素-lr的方法 | |
CN101017168A (zh) | 荧光胶乳定量层析试纸条及其制备方法 | |
CN102087293A (zh) | 一种全程定量检测肌钙蛋白i的免疫层析试纸条及其制备方法 | |
CN102539785A (zh) | 一种全程定量检测c-反应蛋白的荧光免疫层析方法及其试剂盒 | |
CN102520193B (zh) | 一种定量检测人心肌肌钙蛋白i的荧光免疫层析方法及其试剂盒 | |
CN104977409A (zh) | 一种荧光微球免疫层析试纸条的制备及定量检测方法 | |
JP2001124775A (ja) | インフルエンザa型およびb型の存在を視覚的に検出するためのフロースルーアッセイ | |
CN102565382B (zh) | 一种检测血液样本中过敏原特异性IgE抗体的免疫层析方法 | |
US20100304502A1 (en) | Detection method and detection kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Immunochromatography detection card for detecting fluorescent microspheres of ketamine and methyl amphetamine and preparation method thereof Effective date of registration: 20160615 Granted publication date: 20130424 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Zhongde Bio-Engrg Co., Ltd., Jiangxi Registration number: 2016360000008 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 330046 Jiangxi city in Nanchang Province, the provincial government compound Dongsilu dragon building C, Room 308 Patentee after: Jiangxi Sino German bioengineering Limited by Share Ltd Address before: 330029 Jianchang high tech Zone, Nanchang high tech Industrial Park, Overseas Building, South Industrial Park, Jiangxi, China, 306 Patentee before: Jiangxi Zodogenes Biotechnology Co., Ltd. |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170811 Granted publication date: 20130424 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Zhongde Bio-Engrg Co., Ltd., Jiangxi Registration number: 2016360000008 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Immunochromatography detection card for detecting fluorescent microspheres of ketamine and methyl amphetamine and preparation method thereof Effective date of registration: 20170811 Granted publication date: 20130424 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Jiangxi Sino German bioengineering Limited by Share Ltd Registration number: 2017990000738 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180730 Granted publication date: 20130424 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Jiangxi Sino German bioengineering Limited by Share Ltd Registration number: 2017990000738 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Immunochromatography detection card for detecting fluorescent microspheres of ketamine and methyl amphetamine and preparation method thereof Effective date of registration: 20180730 Granted publication date: 20130424 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Jiangxi Sino German bioengineering Limited by Share Ltd Registration number: 2018990000621 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190927 Granted publication date: 20130424 Pledgee: Bank of Beijing, Limited by Share Ltd, Nanchang branch Pledgor: Jiangxi Sino German bioengineering Limited by Share Ltd Registration number: 2018990000621 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |